ACTR-85. THE EFFECT OF REGADENOSON ON TEMOZOLOMIDE NEUROPHARMACOKINETICS IN GLIOBLASTOMA PATIENTS MEASURED BY INTRACEREBRAL MICRODIALYSIS

PURPOSE: The blood-brain barrier (BBB) prevents effective delivery of systemic therapy to the brain. Activation of A(2A) adenosine receptor by regadenoson has demonstrated transient BBB disruption in animals, allowing dextran (70kD) brain entry and increased temozolomide delivery. Temozolomide is th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Jackson, Sadhana, Weingart, Jon, Nduom, Edjah, Holdhoff, Matthias, Blakeley, Jashri, Piotrowski, Anna F, Abd, Thura, George, Richard, McAreavey, Dorothea, Ye, Xiaobu, Anders, Nicole, Peer, Cody, Barnes, Julie, Figg, William, Rudek, Michelle, Gilbert, Mark, Grossman, Stuart A
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5691878/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.071
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires